San Diego-based Profil Institute for Clinical Research, a company focusing on early-phase clinical trials for diabetes and obesity, has appointed Dr. Andrew Krentz senior director of scientific services.
Dr. Krentz, who is currently a senior scientific consultant for Profil Institute, will assume his new position in October following his relocation from the U.K. to San Diego. He will oversee Profil Institute's scientific services department and its integrated, science-driven approach from clinical trial protocol design to the publication of metabolic studies.
"Dr. Krentz has achieved great renown in the U.S. and internationally for his clinical research on the pathogenesis and treatment of diabetes and cardio-metabolic disorders," said Dr. Marcus Hompesch, Profil Institute president and CEO. "The number of clinical trials we perform yearly has doubled since 2006. Dr. Krentz is an important addition to our scientific team and the caliber of his expertise is a perfect fit."
Dr. Krentz comes to Profil Institute from the Bedfordshire and Hertfordshire Postgraduate Medical School where he currently holds an associate professor position within the Institute of Diabetes for Older People (IDOP).